TVTX logo

Travere Therapeutics (TVTX) Total Assets

Annual Total Assets

$788.91 M
+$116.33 M+17.30%

31 December 2023

TVTX Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Assets

$504.41 M
-$46.71 M-8.48%

30 September 2024

TVTX Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TVTX Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+17.3%-39.4%
3 y3 years+29.9%-34.9%
5 y5 years+11.3%-17.8%

TVTX Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+29.9%-39.4%at low
5 y5 yearsat high+30.4%-39.4%at low
alltimeall timeat high>+9999.0%-39.4%>+9999.0%

Travere Therapeutics Total Assets History

DateAnnualQuarterly
Sept 2024
-
$504.41 M(-8.5%)
June 2024
-
$551.12 M(-16.9%)
Mar 2024
-
$663.55 M(-15.9%)
Dec 2023
$788.91 M(+17.3%)
$788.91 M(-5.3%)
Sept 2023
-
$832.85 M(+13.1%)
June 2023
-
$736.43 M(-8.9%)
Mar 2023
-
$808.23 M(+20.2%)
Dec 2022
$672.59 M(-13.4%)
$672.59 M(-7.4%)
Sept 2022
-
$726.22 M(-6.8%)
June 2022
-
$779.49 M(-5.9%)
Mar 2022
-
$828.40 M(+6.7%)
Dec 2021
$776.63 M(+27.9%)
$776.63 M(+0.2%)
Sept 2021
-
$775.08 M(+3.8%)
June 2021
-
$746.77 M(-2.3%)
Mar 2021
-
$764.04 M(+25.8%)
Dec 2020
$607.44 M(+0.4%)
$607.44 M(-12.2%)
Sept 2020
-
$692.22 M(+2.0%)
June 2020
-
$678.69 M(+18.4%)
Mar 2020
-
$573.06 M(-5.2%)
Dec 2019
$604.80 M(-14.7%)
$604.80 M(-1.5%)
Sept 2019
-
$613.82 M(-5.2%)
June 2019
-
$647.57 M(-3.0%)
Mar 2019
-
$667.67 M(-5.9%)
Dec 2018
$709.16 M(+36.3%)
$709.16 M(-1.0%)
Sept 2018
-
$716.19 M(+45.8%)
June 2018
-
$491.14 M(-1.9%)
Mar 2018
-
$500.79 M(-3.8%)
Dec 2017
$520.35 M
$520.35 M(-0.0%)
DateAnnualQuarterly
Sept 2017
-
$520.51 M(+2.6%)
June 2017
-
$507.13 M(-0.6%)
Mar 2017
-
$510.38 M(-2.8%)
Dec 2016
$525.28 M(+2.5%)
$525.28 M(-1.3%)
Sept 2016
-
$532.42 M(-0.3%)
June 2016
-
$533.97 M(+5.3%)
Mar 2016
-
$507.10 M(-1.0%)
Dec 2015
$512.26 M(+278.1%)
$512.26 M(+0.1%)
Sept 2015
-
$511.63 M(+20.3%)
June 2015
-
$425.14 M(+2.2%)
Mar 2015
-
$415.99 M(+207.1%)
Dec 2014
$135.47 M(+560.9%)
$135.47 M(-7.2%)
Sept 2014
-
$145.93 M(-6.2%)
June 2014
-
$155.54 M(+65.4%)
Mar 2014
-
$94.05 M(+358.8%)
Dec 2013
$20.50 M(+757.2%)
$20.50 M(-4.1%)
Sept 2013
-
$21.36 M(+699.4%)
June 2013
-
$2.67 M(-46.0%)
Mar 2013
-
$4.95 M(>+9900.0%)
Dec 2012
$2.39 M(>+9900.0%)
-
Nov 2012
-
$3900.00(0.0%)
Aug 2012
-
$3900.00(0.0%)
May 2012
-
$3900.00(0.0%)
Feb 2012
-
$3900.00(0.0%)
Feb 2012
$3900.00(-2.5%)
-
Nov 2011
-
$3900.00(0.0%)
Aug 2011
-
$3900.00(-2.5%)
Feb 2011
$4000.00
$4000.00

FAQ

  • What is Travere Therapeutics annual total assets?
  • What is the all time high annual total assets for Travere Therapeutics?
  • What is Travere Therapeutics annual total assets year-on-year change?
  • What is Travere Therapeutics quarterly total assets?
  • What is the all time high quarterly total assets for Travere Therapeutics?
  • What is Travere Therapeutics quarterly total assets year-on-year change?

What is Travere Therapeutics annual total assets?

The current annual total assets of TVTX is $788.91 M

What is the all time high annual total assets for Travere Therapeutics?

Travere Therapeutics all-time high annual total assets is $788.91 M

What is Travere Therapeutics annual total assets year-on-year change?

Over the past year, TVTX annual total assets has changed by +$116.33 M (+17.30%)

What is Travere Therapeutics quarterly total assets?

The current quarterly total assets of TVTX is $504.41 M

What is the all time high quarterly total assets for Travere Therapeutics?

Travere Therapeutics all-time high quarterly total assets is $832.85 M

What is Travere Therapeutics quarterly total assets year-on-year change?

Over the past year, TVTX quarterly total assets has changed by -$328.44 M (-39.44%)